Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats

ABSTRACT: This study aimed to evaluate the effects of firocoxib for controlling experimentally-induced breakdown of the blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats. Thirty two cats with no ocular abnormalities were used. Groups (n=8/each) were formed with healthy cats that received 5mg g-1 of oral firocoxib (FH) or no treatment (CH) on day 0; seropositive cats for anti -T. gondii specific immunoglobulin G (IgG) were grouped (n=8/each) and treated in a similar fashion (FT and CT). On day 1, cats of all groups received the same treatment protocol, and 1h later, aqueocentesis was performed under general anesthesia (M0). Following 1h, the same procedure was repeated (M1). Quantitation of aqueous humor total protein and prostaglandin E2 (PGE2) were determined. Aqueous samples of seropositive cats were tested for anti- T. gondii specific IgG. In M0, aqueous samples of CT showed a significantly higher concentration of PGE2 in comparison with other groups (P<0.05). In all groups, PGE2 concentration increased significantly from M0 to M1 (P=0.001). PGE2 values did not change significantly between groups in M1 (P=0.17). Anti- T. gondii specific IgG were reported only in samples of M1, and aqueous titers did not change significantly between FT and CT (P=0.11). Although we have observed that aqueous humor PGE2 levels were significantly higher in cats of CT group during M0, such increase was not able to break the blood-aqueous barrier and cause anterior uveitis. Firocoxib did not prevent intraocular inflammation after aqueocentesis, in healthy and toxoplasmosis-seropositive cats.

Saved in:
Bibliographic Details
Main Authors: Schroder,Deise Cristine, Stocco,Matias Bassinello, Isoton,Deborah de Arruda, Silva,Carla Patricia Amarante e, Braga,Ísis Assis, Silva,Érica Pereira da, Maciel,Camila do Espírito Santo, Maruyama,Fernanda Harumi, Nakazato,Luciano, Aguiar,Daniel Moura de, Mendonça,Adriane Jorge, Ribeiro,Alexandre Pinto
Format: Digital revista
Language:English
Published: Universidade Federal de Santa Maria 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782016000601053
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0103-84782016000601053
record_format ojs
spelling oai:scielo:S0103-847820160006010532016-05-03Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive catsSchroder,Deise CristineStocco,Matias BassinelloIsoton,Deborah de ArrudaSilva,Carla Patricia Amarante eBraga,Ísis AssisSilva,Érica Pereira daMaciel,Camila do Espírito SantoMaruyama,Fernanda HarumiNakazato,LucianoAguiar,Daniel Moura deMendonça,Adriane JorgeRibeiro,Alexandre Pinto aqueous humor intraocular inflammation NSADs toxoplasmosis ABSTRACT: This study aimed to evaluate the effects of firocoxib for controlling experimentally-induced breakdown of the blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats. Thirty two cats with no ocular abnormalities were used. Groups (n=8/each) were formed with healthy cats that received 5mg g-1 of oral firocoxib (FH) or no treatment (CH) on day 0; seropositive cats for anti -T. gondii specific immunoglobulin G (IgG) were grouped (n=8/each) and treated in a similar fashion (FT and CT). On day 1, cats of all groups received the same treatment protocol, and 1h later, aqueocentesis was performed under general anesthesia (M0). Following 1h, the same procedure was repeated (M1). Quantitation of aqueous humor total protein and prostaglandin E2 (PGE2) were determined. Aqueous samples of seropositive cats were tested for anti- T. gondii specific IgG. In M0, aqueous samples of CT showed a significantly higher concentration of PGE2 in comparison with other groups (P<0.05). In all groups, PGE2 concentration increased significantly from M0 to M1 (P=0.001). PGE2 values did not change significantly between groups in M1 (P=0.17). Anti- T. gondii specific IgG were reported only in samples of M1, and aqueous titers did not change significantly between FT and CT (P=0.11). Although we have observed that aqueous humor PGE2 levels were significantly higher in cats of CT group during M0, such increase was not able to break the blood-aqueous barrier and cause anterior uveitis. Firocoxib did not prevent intraocular inflammation after aqueocentesis, in healthy and toxoplasmosis-seropositive cats.info:eu-repo/semantics/openAccessUniversidade Federal de Santa MariaCiência Rural v.46 n.6 20162016-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782016000601053en10.1590/0103-8478cr20151051
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Schroder,Deise Cristine
Stocco,Matias Bassinello
Isoton,Deborah de Arruda
Silva,Carla Patricia Amarante e
Braga,Ísis Assis
Silva,Érica Pereira da
Maciel,Camila do Espírito Santo
Maruyama,Fernanda Harumi
Nakazato,Luciano
Aguiar,Daniel Moura de
Mendonça,Adriane Jorge
Ribeiro,Alexandre Pinto
spellingShingle Schroder,Deise Cristine
Stocco,Matias Bassinello
Isoton,Deborah de Arruda
Silva,Carla Patricia Amarante e
Braga,Ísis Assis
Silva,Érica Pereira da
Maciel,Camila do Espírito Santo
Maruyama,Fernanda Harumi
Nakazato,Luciano
Aguiar,Daniel Moura de
Mendonça,Adriane Jorge
Ribeiro,Alexandre Pinto
Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats
author_facet Schroder,Deise Cristine
Stocco,Matias Bassinello
Isoton,Deborah de Arruda
Silva,Carla Patricia Amarante e
Braga,Ísis Assis
Silva,Érica Pereira da
Maciel,Camila do Espírito Santo
Maruyama,Fernanda Harumi
Nakazato,Luciano
Aguiar,Daniel Moura de
Mendonça,Adriane Jorge
Ribeiro,Alexandre Pinto
author_sort Schroder,Deise Cristine
title Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats
title_short Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats
title_full Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats
title_fullStr Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats
title_full_unstemmed Firocoxib on aqueous humor prostaglandin E 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats
title_sort firocoxib on aqueous humor prostaglandin e 2 levels for controlling experimentally-induced breakdown of blood-aqueous barrier in healthy and toxoplasma gondii -seropositive cats
description ABSTRACT: This study aimed to evaluate the effects of firocoxib for controlling experimentally-induced breakdown of the blood-aqueous barrier in healthy and Toxoplasma gondii -seropositive cats. Thirty two cats with no ocular abnormalities were used. Groups (n=8/each) were formed with healthy cats that received 5mg g-1 of oral firocoxib (FH) or no treatment (CH) on day 0; seropositive cats for anti -T. gondii specific immunoglobulin G (IgG) were grouped (n=8/each) and treated in a similar fashion (FT and CT). On day 1, cats of all groups received the same treatment protocol, and 1h later, aqueocentesis was performed under general anesthesia (M0). Following 1h, the same procedure was repeated (M1). Quantitation of aqueous humor total protein and prostaglandin E2 (PGE2) were determined. Aqueous samples of seropositive cats were tested for anti- T. gondii specific IgG. In M0, aqueous samples of CT showed a significantly higher concentration of PGE2 in comparison with other groups (P<0.05). In all groups, PGE2 concentration increased significantly from M0 to M1 (P=0.001). PGE2 values did not change significantly between groups in M1 (P=0.17). Anti- T. gondii specific IgG were reported only in samples of M1, and aqueous titers did not change significantly between FT and CT (P=0.11). Although we have observed that aqueous humor PGE2 levels were significantly higher in cats of CT group during M0, such increase was not able to break the blood-aqueous barrier and cause anterior uveitis. Firocoxib did not prevent intraocular inflammation after aqueocentesis, in healthy and toxoplasmosis-seropositive cats.
publisher Universidade Federal de Santa Maria
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782016000601053
work_keys_str_mv AT schroderdeisecristine firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT stoccomatiasbassinello firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT isotondeborahdearruda firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT silvacarlapatriciaamarantee firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT bragaisisassis firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT silvaericapereirada firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT macielcamiladoespiritosanto firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT maruyamafernandaharumi firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT nakazatoluciano firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT aguiardanielmourade firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT mendoncaadrianejorge firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
AT ribeiroalexandrepinto firocoxibonaqueoushumorprostaglandine2levelsforcontrollingexperimentallyinducedbreakdownofbloodaqueousbarrierinhealthyandtoxoplasmagondiiseropositivecats
_version_ 1756406409800450048